FDA’s Next Step to Real-World Evidence: Prove That Real-World Studies Can Match Known RCT Results

Industry is eager to develop approval pathways that rely on “real world” evidence from insurance claims and electronic health records. FDA, however, thinks the next step needs to be develop and validate the methodology.